Neuralgia, Postherpetic Clinical Trial
Official title:
A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study To Evaluate Efficacy And Safety Of Pregabalin In The Treatment Of Postherpetic Neuralgia
The purpose of this study is to evaluate efficacy and safety of pregabalin in the treatment of postherpetic neuralgia in a dose-ranging manner.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02484170 -
Mannitol Cream for Post Herpetic Neuralgia
|
Phase 1/Phase 2 | |
Terminated |
NCT00964990 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain (Postherpetic Neuralgia and Post-traumatic Neuralgia)
|
Phase 2 | |
Completed |
NCT01252160 -
Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage
|
Phase 4 | |
Completed |
NCT00377598 -
Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia
|
Phase 2/Phase 3 | |
Completed |
NCT00160667 -
A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia)
|
Phase 2 | |
Terminated |
NCT00245544 -
Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004)
|
Phase 2 | |
Completed |
NCT00335933 -
Safety and Efficacy of Gabapentin in Postherpetic Neuralgia
|
Phase 3 | |
Completed |
NCT00617461 -
A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment
|
Phase 2 | |
Withdrawn |
NCT02426411 -
Dose Ranging Trial to Determine the Safety and Efficacy of EMA401 in Patients With PHN
|
Phase 2 | |
Completed |
NCT01129531 -
A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia
|
Phase 2 | |
Completed |
NCT00674687 -
A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory Testing
|
N/A | |
Terminated |
NCT01678924 -
A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia
|
Phase 2 | |
Completed |
NCT00424372 -
A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia
|
Phase 3 | |
Completed |
NCT00619476 -
A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN)
|
Phase 2 | |
Terminated |
NCT00295776 -
Lamictal in the Treatment of Post-Herpetic Neuralgia
|
Phase 2/Phase 3 | |
Completed |
NCT00570310 -
Neuropathic Pain Syndrome Patient Study (MK-0000-072)
|
Phase 1 | |
Terminated |
NCT00282763 -
A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)
|
Phase 2 | |
Completed |
NCT00568321 -
RN624 For Pain Of Post-Herpetic Neuralgia
|
Phase 2 | |
Not yet recruiting |
NCT01102101 -
Effect of Opioids in Neuropathic Pain in Postherpetic Patients
|
Phase 3 | |
Completed |
NCT00614705 -
PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia
|
Phase 2 |